Top

Published in:

01-02-2017 | Therapeutic Aspects in Autoimmunity

Postural tachycardia syndrome (POTS) with anti-NMDA receptor antibodies after human papillomavirus vaccination

Authors: Svetlana Blitshteyn, Jill Brook

Published in: Immunologic Research | Issue 1/2017

Abstract

We describe a young woman who developed POTS with positive serum anti-NMDA receptor antibodies and no evidence of encephalitis after vaccination with HPV vaccine, Cervarix. Her symptoms improved significantly with immunomodulatory therapy and re-occurred after immunomodulatory therapy was stopped, suggesting an autoimmune etiology of POTS after vaccination.

Thieben MJ, Sandroni P, Sletten DM, et al. Postural orthostatic tachycardia syndrome: the Mayo Clinic experience. Mayo Clin Proc. 2007;82:308–13.CrossRefPubMed

Dalmau J, Lancaster E, Martinez-Hernandez E, et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol. 2011;10:63–74.CrossRefPubMedPubMedCentral

Blitshteyn S. Postural tachycardia syndrome following human papillomavirus vaccination. Eur J Neurol. 2014;21:135–9.CrossRefPubMed

Brinth L, Thiebel AC, Pors K, Melson J. Suspected side effects to the quadrivalent human papilloma vaccine. Dan Med J. 2015;62:A5064.PubMed

Li H, Yu X, Liles C, et al. Autoimmune basis for postural tachycardia syndrome. J Am Heart Assoc. 2014;3:e000755. doi:10.1161/JAHA.113.000755.CrossRefPubMedPubMedCentral

Dubey D, Hopkins S, Vernino S. M1 and M2 muscarinic receptor antibodies among patients with postural orthostatic tachycardia syndrome: potential disease biomarker. J Clin Neuromuscul Dis. 2016;17:99–180 Abstract.CrossRef

Dahan S, Tomljenovic L, Shoenfeld Y. Postural orthostatic tachycardia syndrome (POTS): a novel member of the autoimmune family. Lupus. 2016;25:339–42.CrossRefPubMed

Hendrickson JE, Tormey CA. Human papilloma virus vaccination and dysautonomia: consideration for autoantibody evaluation and HLA typing. Vaccine. 2016;34:4468.CrossRefPubMed

Blitshteyn S. Autoimmune markers and autoimmune disorders in patients with postural tachycardia syndrome (POTS). Lupus. 2015;24:1364–9.CrossRefPubMed

10.

Hofmann C, Baur M-O, Schroten H. Anti-NMDA receptor encephalitis after TdaP-IPV booster vaccination: cause or coincidence? J Neurol. 2011;258:500–1.CrossRefPubMed

Title: Postural tachycardia syndrome (POTS) with anti-NMDA receptor antibodies after human papillomavirus vaccination
Authors: Svetlana Blitshteyn
Jill Brook
Publication date: 01-02-2017
Publisher: Springer US
Published in: Immunologic Research / Issue 1/2017
Print ISSN: 0257-277X
Electronic ISSN: 1559-0755
DOI: https://doi.org/10.1007/s12026-016-8855-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Postural tachycardia syndrome (POTS) with anti-NMDA receptor antibodies after human papillomavirus vaccination

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2017

Glaucoma: recent advances in the involvement of autoimmunity

Novel clinical and therapeutic aspects in autoimmunity

Antiphospholipid syndrome (APS) revisited: Would migraine headaches be included in future classification criteria?

Biomarkers and Pathogenic Mechanisms in Autoimmunity

Guillain–Barré syndrome in Colombia: where do we stand now?

Long-term use of hydroxychloroquine reduces antiphospholipid antibodies levels in patients with primary antiphospholipid syndrome